TRACE Study group. TRAndolapril Cardiac Evaluation. Eur Heart J. 1999;20:748 54. S7.4-21. McMurray J, K ber L, Robertson M, et al. Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial. J Am Coll Cardiol. 2005;45:525 30. S7.4-22. Fauchier L, Lecoq C, Ancedy Y, et al. Evaluation of 5 prognostic scores for prediction of stroke, thromboembolic and coronary events, all-cause mortality, and major adverse cardiac events in patients with atrial fibrillation and coronary stenting. Am J Cardiol. 2016;118:700 7. S7.4 23. lvarez- lvarez B, Raposeiras-Roub n S, Abu-Assi E, et al. Is 6-month GRACE risk score a useful tool to predict stroke after an acute coro- nary syndrome? Open Heart. 2014;1:e000123. S7.4-24. Bristol-Myers Squibb. A study of apixaban in patients with atrial fibrillation, not caused by a heart valve problem, who are at risk for thrombosis (blood clots) due to having had a recent coronary event, such as a heart attack or a procedure to open the vessels of the heart. Available at: https://www.clinicaltrials.gov. Identifier: NCT02415400. Accessed November 1, 2017. S7.4-25. Daiichi Sankyo, Inc. Edoxaban treatment versus vitamin K antago- nist in patients with atrial fibrillation undergoing percutaneous coronary intervention (ENTRUST-AF-PCI). Available at: https://www. clinicaltrials.gov. Identifier: NCT02866175. Accessed November 1, 2017. 7.12. Device Detection of AF and Atrial Flutter (New Section) S7.12-1. Boriani G, Glotzer TV, Santini M, et al. Device-detected atrial fibrillation and risk for stroke: an analysis of >10 000 patients from the SOS AF project (Stroke prevention Strategies based on Atrial Fibrillation information from implanted devices). Eur Heart J. 2014;35:508 16. S7.12-2. Glotzer TV, Daoud EG, Wyse DG, et al. The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study. Circ Arrhythm Electrophysiol. 2009;2:474 80. S7.12-3. 